These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9514933

  • 1. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC, Bennett RG, Hamel FG.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):390-4. PubMed ID: 9514933
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM, Bennett RG, Siford GL, Hamel FG.
    Biochem Pharmacol; 2009 Mar 15; 77(6):1064-73. PubMed ID: 19154729
    [Abstract] [Full Text] [Related]

  • 3. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG, Fawcett J, Tsui BT, Bennett RG, Duckworth WC.
    Diabetes Obes Metab; 2006 Nov 15; 8(6):661-8. PubMed ID: 17026490
    [Abstract] [Full Text] [Related]

  • 4. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
    Bennett RG, Fawcett J, Kruer MC, Duckworth WC, Hamel FG.
    J Endocrinol; 2003 Jun 15; 177(3):399-405. PubMed ID: 12773120
    [Abstract] [Full Text] [Related]

  • 5. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
    Fawcett J, Permana PA, Levy JL, Duckworth WC.
    Arch Biochem Biophys; 2007 Dec 01; 468(1):128-33. PubMed ID: 17964527
    [Abstract] [Full Text] [Related]

  • 6. Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase.
    Bennett RG, Hamel FG, Duckworth WC.
    Biochem Biophys Res Commun; 1994 Jul 29; 202(2):1047-53. PubMed ID: 8048917
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG, Hamel FG, Duckworth WC.
    Diabetes; 1997 Feb 29; 46(2):197-203. PubMed ID: 9000694
    [Abstract] [Full Text] [Related]

  • 8. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme.
    Hamel FG, Bennett RG, Duckworth WC.
    Endocrinology; 1998 Oct 29; 139(10):4061-6. PubMed ID: 9751483
    [Abstract] [Full Text] [Related]

  • 9. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome.
    Bennett RG, Hamel FG, Duckworth WC.
    Endocrinology; 2000 Jul 29; 141(7):2508-17. PubMed ID: 10875252
    [Abstract] [Full Text] [Related]

  • 10. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase.
    Duckworth WC, Bennett RG, Hamel FG.
    J Biol Chem; 1994 Oct 07; 269(40):24575-80. PubMed ID: 7929129
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
    Harada S, Smith RM, Hu DQ, Jarett L.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):154-8. PubMed ID: 8573122
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the inhibition of protein degradation by insulin in L6 cells.
    Fawcett J, Hamel FG, Duckworth WC.
    Arch Biochem Biophys; 2001 Jan 15; 385(2):357-63. PubMed ID: 11368017
    [Abstract] [Full Text] [Related]

  • 13. Preliminary report: inhibition of cellular proteasome activity by free fatty acids.
    Hamel FG.
    Metabolism; 2009 Aug 15; 58(8):1047-9. PubMed ID: 19423142
    [Abstract] [Full Text] [Related]

  • 14. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA, George AM, Eisenhauer PB, Conn K, Gao W, Carreras I, Wells JM, McKee A, Ullman MD, Fine RE.
    J Neurosci Res; 2006 May 15; 83(7):1262-70. PubMed ID: 16511862
    [Abstract] [Full Text] [Related]

  • 15. Insulin-degrading enzyme.
    Authier F, Posner BI, Bergeron JJ.
    Clin Invest Med; 1996 Jun 15; 19(3):149-60. PubMed ID: 8724818
    [Abstract] [Full Text] [Related]

  • 16. Insulin-degrading enzyme hydrolyzes ATP.
    Del Carmen Camberos M, Cresto JC.
    Exp Biol Med (Maywood); 2007 Feb 15; 232(2):281-92. PubMed ID: 17259336
    [Abstract] [Full Text] [Related]

  • 17. Degradation of pro-insulin-receptor proteins by proteasomes.
    Cruz M, Velasco E, Kumate J.
    Arch Med Res; 2004 Feb 15; 35(1):18-23. PubMed ID: 15036795
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
    Li CZ, Zhang SH, Shu CD, Ren W.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb 15; 22(2):151-4. PubMed ID: 12390813
    [Abstract] [Full Text] [Related]

  • 19. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W, Leissring MA, Hemming ML, Chang AY, Selkoe DJ.
    Biochemistry; 2005 May 03; 44(17):6513-25. PubMed ID: 15850385
    [Abstract] [Full Text] [Related]

  • 20. The ubiquitin-proteasome system is responsible for cysteine-responsive regulation of cysteine dioxygenase concentration in liver.
    Stipanuk MH, Hirschberger LL, Londono MP, Cresenzi CL, Yu AF.
    Am J Physiol Endocrinol Metab; 2004 Mar 03; 286(3):E439-48. PubMed ID: 14644768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.